Trametinib-impurities | Pharmaffiliates

trametinib

Trametinib may be used alone or in combination with another medication to treat a type of skin cancer. It is a MEK inhibitor drug with anti-cancer activity.Reference standards of Trametinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Trametinib-d4
    [catalogue_number] => PA STI 084082
    [category_ids] => ,79,80,71,78,70,82,98,
    [chemical_name] => 
    [weight] => 619.42
    [form] => C26H19D4FIN5O4
    [cas] => NA
    [pslug] => trametinib-d4-pasti084082
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 084082

Trametinib-d4


  • Catalogue No.:PA STI 084082

  • CAS :

    NA

  • Molecular Formula : C26H19D4FIN5O4

  • Molecular Weight : 619.42